Morrow C, Fehler F (2004) Marek’s disease: an evolving problem. In: Davison F, Nair V (eds) Marek’s disease: a worldwide problem. Elsevier Academic Press, London, pp 49–61
Chapter
Google Scholar
Gimeno IM, Witter RL, Reed WM (1999) Four distinct neurologic syndromes in Marek’s disease: effect of viral strain and pathotype. Avian Dis 43:721–737
Article
CAS
PubMed
Google Scholar
Witter RL, Solomon JJ (1972) Experimental infection of turkeys and chickens with a herpesvirus of turkeys (HVT). Avian Dis 16:34–44
Article
CAS
PubMed
Google Scholar
Afonso CL, Tulman ER, Lu Z, Zsak L, Rock DL, Kutish GF (2001) The genome of turkey herpesvirus. J Virol 75:971–978
Article
CAS
PubMed
PubMed Central
Google Scholar
Davidson F (2004) Marek’s disease: an evolving problem. Elsevier Academic Press, London
Google Scholar
Gimeno IM, Cortes AL, Montiel ER, Lemiere S, Pandiri AK (2011) Effect of diluting Marek’s disease vaccines on the outcomes of Marek’s disease virus infection when challenged with highly virulent Marek’s disease viruses. Avian Dis 55:263–272
Article
PubMed
Google Scholar
Davison F, Nair V (2005) Use of Marek’s disease vaccines: could they be driving the virus to increasing virulence? Expert Rev Vaccines 4:77–88
Article
PubMed
Google Scholar
Gimeno IM, Cortes AL, Silva RF (2008) Load of challenge Marek’s disease virus DNA in blood as a criterion for early diagnosis of Marek’s disease tumors. Avian Dis 52:203–208
Article
PubMed
Google Scholar
Read AF, Baigent SJ, Powers C, Kgosana LB, Blackwell L, Smith LP, Kennedy DA, Walkden-Brown SW, Nair VK (2015) Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biol 13:e1002198
Article
PubMed
PubMed Central
CAS
Google Scholar
Zerboni L, Sen N, Oliver SL, Arvin AM (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12:197–210
Article
CAS
PubMed
PubMed Central
Google Scholar
Nazerian K, Witter RL (1970) Cell-free transmission and in vivo replication of Marek’s disease virus. J Virol 5:388–397
CAS
PubMed
PubMed Central
Google Scholar
Abdul-Careem MF, Javaheri-Vayeghan A, Shanmuganathan S, Haghighi HR, Read LR, Haq K, Hunter DB, Schat KA, Heidari M, Sharif S (2009) Establishment of an aerosol-based Marek’s disease virus infection model. Avian Dis 53:387–391
Article
PubMed
Google Scholar
Abdul-Careem MF, Read LR, Parvizi P, Thanthrige-Don N, Sharif S (2009) Marek’s disease virus-induced expression of cytokine genes in feathers of genetically defined chickens. Dev Comp Immunol 33:618–623
Article
CAS
PubMed
Google Scholar
Calnek BW (1986) Marek’s disease–a model for herpesvirus oncology. Crit Rev Microbiol 12:293–320
Article
CAS
PubMed
Google Scholar
Calnek BW (2001) Pathogenesis of Marek’s disease virus infection. Curr Top Microbiol Immunol 255:25–55
CAS
PubMed
Google Scholar
St Hill CA, Silva RF, Sharma JM (2004) Detection and localization of avian alphaherpesviruses in embryonic tissues following in ovo exposure. Virus Res 100:243–248
Article
CAS
PubMed
Google Scholar
Abdul-Careem MF, Haq K, Shanmuganathan S, Read LR, Schat KA, Heidari M, Sharif S (2009) Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek’s disease virus. Virology 393:250–257
Article
CAS
PubMed
Google Scholar
Purchase HG (1970) Virus-specific immunofluorescent and precipitin antigens and cell-free virus in the tissues of birds infected with Marek’s disease. Cancer Res 30:1898–1908
CAS
PubMed
Google Scholar
Butter C, Staines K, Baaten B, Smith L, Davison TF (2007) Route of challenge is critical in determining the clinical outcome of infection with a very virulent oncogenic herpesvirus, Marek’s disease virus. Avian Pathol 36:93–99
Article
CAS
PubMed
Google Scholar
Barrow AD, Burgess SC, Baigent SJ, Howes K, Nair VK (2003) Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek’s disease virus. J Gen Virol 84:2635–2645
Article
CAS
PubMed
Google Scholar
Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA (2005) Classification of Marek’s disease viruses according to pathotype: philosophy and methodology. Avian Pathol 34:75–90
Article
CAS
PubMed
Google Scholar
Engel AT, Selvaraj RK, Kamil JP, Osterrieder N, Kaufer BB (2012) Marek’s disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells. J Virol 86:8536–8545
Article
CAS
PubMed
PubMed Central
Google Scholar
Parcells MS, Lin SF, Dienglewicz RL, Majerciak V, Robinson DR, Chen HC, Wu Z, Dubyak GR, Brunovskis P, Hunt HD, Lee LF, Kung HJ (2001) Marek’s disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75:5159–5173
Article
CAS
PubMed
PubMed Central
Google Scholar
Gesser B, Lund M, Lohse N, Vestergaad C, Matsushima K, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG (1996) IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J Leukoc Biol 59:407–411
CAS
PubMed
Google Scholar
Baaten BJ, Staines KA, Smith LP, Skinner H, Davison TF, Butter C (2009) Early replication in pulmonary B cells after infection with Marek’s disease herpesvirus by the respiratory route. Viral Immunol 22:431–444
Article
CAS
PubMed
Google Scholar
Omar AR, Schat KA (1996) Syngeneic Marek’s disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology 222:87–99
Article
CAS
PubMed
Google Scholar
Omar AR, Schat KA (1997) Characterization of Marek’s disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology 90:579–585
Article
CAS
PubMed
PubMed Central
Google Scholar
Reddy SM, Lupiani B, Gimeno IM, Silva RF, Lee LF, Witter RL (2002) Rescue of a pathogenic Marek’s disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc Natl Acad Sci USA 99:7054–7059
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee LF, Cui X, Cui Z, Gimeno I, Lupiani B, Reddy SM (2005) Characterization of a very virulent Marek’s disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens. Virus Genes 31:73–80
Article
CAS
PubMed
Google Scholar
Gimeno IM, Witter RL, Hunt HD, Reddy SM, Lee LF, Silva RF (2005) The pp38 gene of Marek’s disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV. J Virol 79:4545–4549
Article
CAS
PubMed
PubMed Central
Google Scholar
Biggs PM, Nair V (2012) The long view: 40 years of Marek’s disease research and Avian pathology. Avian Pathol 41:3–9
Article
PubMed
Google Scholar
Morissette G, Flamand L (2010) Herpesviruses and chromosomal integration. J Virol 84:12100–12109
Article
CAS
PubMed
PubMed Central
Google Scholar
Robinson CM, Cheng HH, Delany ME (2014) Temporal kinetics of Marek’s disease herpesvirus: integration occurs early after infection in both B and T cells. Cytogenet Genome Res 144:142–154
Article
CAS
PubMed
Google Scholar
Delecluse HJ, Hammerschmidt W (1993) Status of Marek’s disease virus in established lymphoma cell lines: herpesvirus integration is common. J Virol 67:82–92
CAS
PubMed
PubMed Central
Google Scholar
Lupiani B, Lee LF, Cui X, Gimeno I, Anderson A, Morgan RW, Silva RF, Witter RL, Kung HJ, Reddy SM (2004) Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci USA 101:11815–11820
Article
CAS
PubMed
PubMed Central
Google Scholar
Haq K, Schat KA, Sharif S (2013) Immunity to Marek’s disease: where are we now? Dev Comp Immunol 41:439–446
Article
CAS
PubMed
Google Scholar
Mwangi WN, Smith LP, Baigent SJ, Beal RK, Nair V, Smith AL (2011) Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells. PLoS Pathog 7:e1001337
Article
CAS
PubMed
PubMed Central
Google Scholar
Remy S, Blondeau C, Le Vern Y, Lemesle M, Vautherot JF, Denesvre C (2013) Fluorescent tagging of VP22 in N-terminus reveals that VP22 favors Marek’s disease virus (MDV) virulence in chickens and allows morphogenesis study in MD tumor cells. Vet Res 44:125
Article
PubMed
PubMed Central
CAS
Google Scholar
Jarosinski KW, Arndt S, Kaufer BB, Osterrieder N (2012) Fluorescently tagged pUL47 of Marek’s disease virus reveals differential tissue expression of the tegument protein in vivo. J Virol 86:2428–2436
Article
CAS
PubMed
PubMed Central
Google Scholar
Abdul-Careem MF, Hunter BD, Sarson AJ, Parvizi P, Haghighi HR, Read L, Heidari M, Sharif S (2008) Host responses are induced in feathers of chickens infected with Marek’s disease virus. Virology 370:323–332
Article
CAS
PubMed
Google Scholar
Abdul-Careem MF, Hunter DB, Shanmuganathan S, Haghighi HR, Read L, Heidari M, Sharif S (2008) Cellular and cytokine responses in feathers of chickens vaccinated against Marek’s disease. Vet Immunol Immunopathol 126:362–366
Article
CAS
PubMed
Google Scholar
Ahmed M, Schidlovsky G (1968) Electron microscopic localization of herpesvirus-type particles in Marek’s disease. J Virol 2:1443–1457
CAS
PubMed
PubMed Central
Google Scholar
Churchill AE, Biggs PM (1967) Agent of Marek’s disease in tissue culture. Nature 215:528–530
Article
CAS
PubMed
Google Scholar
Harmache A (2014) A virulent bioluminescent and fluorescent dual-reporter Marek’s disease virus unveils an alternative spreading pathway in addition to cell-to-cell contact. J Virol 88:11617–11623
Article
PubMed
PubMed Central
CAS
Google Scholar
Heidari M, Fitzgerald SD, Zhang HM, Silva RF, Lee LF, Dunn JR (2007) Marek’s disease virus-induced skin leukosis in scaleless chickens: tumor development in the absence of feather follicles. Avian Dis 51:713–718
Article
CAS
PubMed
Google Scholar
Couteaudier M, Denesvre C (2014) Marek’s disease virus and skin interactions. Vet Res 45:36
Article
PubMed
PubMed Central
Google Scholar
Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, Parcells MS, Kumar PM, Tregaskes CA, Lee LF, Davison TF (2004) Marek’s disease is a natural model for lymphomas overexpressing Hodgkin’s disease antigen (CD30). Proc Natl Acad Sci USA 101:13879–13884
Article
CAS
PubMed
PubMed Central
Google Scholar
Murata S, Hayashi Y, Kato A, Isezaki M, Takasaki S, Onuma M, Osa Y, Asakawa M, Konnai S, Ohashi K (2012) Surveillance of Marek’s disease virus in migratory and sedentary birds in Hokkaido, Japan. Vet J 192:538–540
Article
PubMed
Google Scholar
Haesendonck R, Garmyn A, Dorrestein GM, Hellebuyck T, Antonissen G, Pasmans F, Ducatelle R, Martel A (2015) Marek’s disease virus associated ocular lymphoma in Roulroul partridges (Rollulus rouloul). Avian Pathol 44:347–351
Article
CAS
PubMed
Google Scholar
Miller DM, Sedmak DD (1999) Viral effects on antigen processing. Curr Opin Immunol 11:94–99
Article
CAS
PubMed
Google Scholar
Hunt HD, Lupiani B, Miller MM, Gimeno I, Lee LF, Parcells MS (2001) Marek’s disease virus down-regulates surface expression of MHC (B Complex) Class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology 282:198–205
Article
CAS
PubMed
Google Scholar
Hearn C, Preeyanon L, Hunt HD, York IA (2015) An MHC class I immune evasion gene of Marek’s disease virus. Virology 475:88–95
Article
CAS
PubMed
Google Scholar
Jarosinski KW, Hunt HD, Osterrieder N (2010) Down-regulation of MHC class I by the Marek’s disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion. Virology 405:457–463
Article
CAS
PubMed
Google Scholar
Niikura M, Kim T, Hunt HD, Burnside J, Morgan RW, Dodgson JB, Cheng HH (2007) Marek’s disease virus up-regulates major histocompatibility complex class II cell surface expression in infected cells. Virology 359:212–219
Article
CAS
PubMed
Google Scholar
Gimeno IM, Witter RL, Hunt HD, Lee LF, Reddy SM, Neumann U (2001) Marek’s disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression. Vet Pathol 38:491–503
Article
CAS
PubMed
Google Scholar
Stevanovic S, van Bergen CA, van Luxemburg-Heijs SA, van der Zouwen B, Jordanova ES, Kruisselbrink AB, van de Meent M, Harskamp JC, Claas FH, Marijt EW, Zwaginga JJ, Halkes CJ, Jedema I, Griffioen M, Falkenburg JH (2013) HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Blood 122:1963–1973
Article
CAS
PubMed
Google Scholar
Kimmel PL, Cohen DJ, Abraham AA, Bodi I, Schwartz AM, Phillips TM (2003) Upregulation of MHC class II, interferon-alpha and interferon-gamma receptor protein expression in HIV-associated nephropathy. Nephrol Dial Transplant 18:285–292
Article
CAS
PubMed
Google Scholar
Cui X, Lee LF, Reed WM, Kung HJ, Reddy SM (2004) Marek’s disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J Virol 78:4753–4760
Article
CAS
PubMed
PubMed Central
Google Scholar
Heidari M, Fitzgerald SD, Zhang H (2015) Immune responses in cecal tonsils of Marek’s disease virus-infected chickens. Avian Dis 59:213–226
Article
PubMed
Google Scholar
Baigent SJ, Ross LJ, Davison TF (1998) Differential susceptibility to Marek’s disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes. J Gen Virol 79:2795–2802
Article
CAS
PubMed
Google Scholar
Calnek BW, Schat KA, Ross LJ, Chen CL (1984) Further characterization of Marek’s disease virus-infected lymphocytes. II In vitro infection. Int J Cancer 33:399–406
Article
CAS
PubMed
Google Scholar
Wu P, Reed WM, Lee LF (2001) Glycoproteins H and L of Marek’s disease virus form a hetero-oligomer essential for translocation and cell surface expression. Arch Virol 146:983–992
Article
CAS
PubMed
Google Scholar
Schumacher D, Tischer BK, Reddy SM, Osterrieder N (2001) Glycoproteins E and I of Marek’s disease virus serotype 1 are essential for virus growth in cultured cells. J Virol 75:11307–11318
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, Lisinski I, Cushman SW, Jacobson S, Ruscetti FW (2006) Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol 80:8291–8302
Article
CAS
PubMed
PubMed Central
Google Scholar
Subramaniam S, Preeyanon L, Cheng HH (2013) Transcriptional profiling of mEq-dependent genes in Marek’s disease resistant and susceptible inbred chicken lines. PLoS One 8:e78171
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu S, Xue C, Li J, Bi Y, Cao Y (2011) Marek’s disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol 85:276–285
Article
CAS
PubMed
Google Scholar
Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V (2011) Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek’s disease lymphomas. PLoS Pathog 7:e1001305
Article
CAS
PubMed
PubMed Central
Google Scholar
Chi JQ, Teng M, Yu ZH, Xu H, Su JW, Zhao P, Xing GX, Liang HD, Deng RG, Qu LH, Zhang GP, Luo J (2015) Marek’s disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-beta signaling pathway. Virology 476:72–84
Article
CAS
PubMed
Google Scholar
Heidari M, Fitzgerald SD, Zhang H (2014) Marek’s disease virus-induced transient cecal tonsil atrophy. Avian Dis 58:262–270
Article
PubMed
Google Scholar
Weller SK (2011) Alphaherpesviruses: molecular virology. Caister Academic, Norfolk
Google Scholar
Gonzalez-Navajas JM, Lee J, David M, Raz E (2012) Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125–135
CAS
PubMed
PubMed Central
Google Scholar
Fitzgerald-Bocarsly P, Dai J, Singh S (2008) Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 19:3–19
Article
CAS
PubMed
PubMed Central
Google Scholar
Toth TE (2000) Nonspecific cellular defense of the avian respiratory system: a review. Dev Comp Immunol 24:121–139
Article
CAS
PubMed
Google Scholar
Quere P, Rivas C, Ester K, Novak R, Ragland WL (2005) Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek’s disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription. Arch Virol 150:507–519
Article
CAS
PubMed
Google Scholar
Karaca G, Anobile J, Downs D, Burnside J, Schmidt CJ (2004) Herpesvirus of turkeys: microarray analysis of host gene responses to infection. Virology 318:102–111
Article
CAS
PubMed
Google Scholar
Morgan RW, Sofer L, Anderson AS, Bernberg EL, Cui J, Burnside J (2001) Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek’s disease virus. J Virol 75:533–539
Article
CAS
PubMed
PubMed Central
Google Scholar
Xing Z, Schat KA (2000) Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek’s disease virus. J Virol 74:3605–3612
Article
CAS
PubMed
PubMed Central
Google Scholar
Feng ZQ, Lian T, Huang Y, Zhu Q, Liu YP (2013) Expression pattern of genes of RLR-mediated antiviral pathway in different-breed chicken response to Marek’s disease virus infection. Biomed Res Int 2013:419256
PubMed
PubMed Central
Google Scholar
Jarosinski KW, Jia W, Sekellick MJ, Marcus PI, Schat KA (2001) Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek’s disease virus expressing IFN-alpha. J Interferon Cytokine Res 21:287–296
Article
CAS
PubMed
Google Scholar
Biron CA (2012) Yet another role for natural killer cells: cytotoxicity in immune regulation and viral persistence. Proc Natl Acad Sci USA 109:1814–1815
Article
CAS
PubMed
PubMed Central
Google Scholar
Koren S, Fleischmann WR Jr (1993) Orally administered interferons suppress bone marrow function. Proc Soc Exp Biol Med 204:155–164
Article
CAS
PubMed
Google Scholar
De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW (2010) Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS One 5:e13076
Article
PubMed
PubMed Central
CAS
Google Scholar
Haq K, Elawadli I, Parvizi P, Mallick AI, Behboudi S, Sharif S (2011) Interferon-gamma influences immunity elicited by vaccines against very virulent Marek’s disease virus. Antiviral Res 90:218–226
Article
CAS
PubMed
Google Scholar
Powell PC, Hartley KJ, Mustill BM, Rennie M (1983) Studies on the role of macrophages in Marek’s disease of the chicken. J Reticuloendothel Soc 34:289–297
CAS
PubMed
Google Scholar
Kodama H, Mikami T, Inoue M, Izawa H (1979) Inhibitory effects of macrophages against Marek’s disease virus plaque formation in chicken kidney cell cultures. J Natl Cancer Inst 63:1267–1271
CAS
PubMed
Google Scholar
Gupta MK, Chauhan HV, Jha GJ, Singh KK (1989) The role of the reticuloendothelial system in the immunopathology of Marek’s disease. Vet Microbiol 20:223–234
Article
CAS
PubMed
Google Scholar
Djeraba A, Bernardet N, Dambrine G, Quéré P (2000) Nitric oxide inhibits Marek’s disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. Virology 277:58–65
Article
CAS
PubMed
Google Scholar
Jarosinski KW, Njaa BL, O’Connell PH, Schat KA (2005) Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek’s disease virus. Viral Immunol 18:148–161
Article
CAS
PubMed
Google Scholar
Djeraba A, Musset E, Bernardet N, Le Vern Y, Quéré P (2002) Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek’s disease. Vet Immunol Immunopathol 85:63–75
Article
CAS
PubMed
Google Scholar
Qureshi MA, Miller L (1991) Signal requirements for the acquisition of tumoricidal competence by chicken peritoneal macrophages. Poult Sci 70:530–538
Article
CAS
PubMed
Google Scholar
Ostuni R, Kratochvill F, Murray PJ, Natoli G (2015) Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol 36:229–239
Article
CAS
PubMed
Google Scholar
Lee LF, Sharma JM, Nazerian K, Witter RL (1978) Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek’s disease virus. J Immunol 120:1554–1559
CAS
PubMed
Google Scholar
Garcia-Camacho L, Schat KA, Brooks R, Bounous D (2003) Early cell-mediated immune responses to Marek’s disease virus in two chicken lines with defined major histocompatibility complex antigens. Vet Immunol Immunopathol 95:145–153
Article
CAS
PubMed
Google Scholar
Sarson AJ, Abdul-Careem MF, Read LR, Brisbin JT, Sharif S (2008) Expression of cytotoxicity-associated genes in Marek’s disease virus-infected chickens. Viral Immunol 21:267–272
Article
CAS
PubMed
Google Scholar
Queré P, Dambrine G (1988) Development of anti-tumoral cell-mediated cyto-toxicity during the course of Marek’s disease in chickens. Ann Rech Vet 19:193–201
PubMed
Google Scholar
Neulen ML, Viertlboeck BC, Straub C, Gobel TW (2015) Identification of novel chicken CD4(+) CD3(−) blood population with NK cell like features. Dev Comp Immunol 49:72–78
Article
CAS
PubMed
Google Scholar
Churchil AE, Payne LN, Chubb RC (1969) Immunization against Marek’s disease using a live attenuated virus. Nature 221:744–747
Article
Google Scholar
Schat KA, Markowski-Grimsrud CJ (2001) Immune responses to Marek’s disease virus infection. Curr Top Microbiol Immunol 255:91–120
CAS
PubMed
Google Scholar
Edwards KM (2015) Maternal antibodies and infant immune responses to vaccines. Vaccine 33:6469–6472
Article
CAS
PubMed
Google Scholar
Endsley JJ, Roth JA, Ridpath J, Neill J (2003) Maternal antibody blocks humoral but not T cell responses to BVDV. Biologicals 31:123–125
Article
CAS
PubMed
Google Scholar
Siegrist CA, Barrios C, Martinez X, Brandt C, Berney M, Cordova M, Kovarik J, Lambert PH (1998) Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 28:4138–4148
Article
CAS
PubMed
Google Scholar
Niewiesk S (2014) Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 5:446
Article
PubMed
PubMed Central
CAS
Google Scholar
Bandrick M, Theis K, Molitor TW (2014) Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets. BMC Vet Res 10:124
Article
PubMed
PubMed Central
CAS
Google Scholar
Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM (2003) Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21:3398–3405
Article
CAS
PubMed
Google Scholar
White DW, Suzanne Beard R, Barton ES (2012) Immune modulation during latent herpesvirus infection. Immunol Rev 245:189–208
Article
CAS
PubMed
PubMed Central
Google Scholar
Hanley PJ, Bollard CM (2014) Controlling cytomegalovirus: helping the immune system take the lead. Viruses 6:2242–2258
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharma JM, Witter RL (1975) The effect of B-cell immunosuppression on age-related resistance of chickens to Marek’s disease. Cancer Res 35:711–717
CAS
PubMed
Google Scholar
Markowski-Grimsrud CJ, Schat KA (2002) Cytotoxic T lymphocyte responses to Marek’s disease herpesvirus-encoded glycoproteins. Vet Immunol Immunopathol 90:133–144
Article
CAS
PubMed
Google Scholar
Gupta SK, Kharole MU, Kalra DS (1982) Role of thymus-dependent immune system in HVT protection against Marek’s disease. Avian Dis 26:7–13
Article
CAS
PubMed
Google Scholar
Purchase HG, Sharma JM (1974) Amelioration of Marek’s disease and absence of vaccine protection in immunologically deficient chickens. Nature 248:419–421
Article
CAS
PubMed
Google Scholar
Morimura T, Ohashi K, Sugimoto C, Onuma M (1998) Pathogenesis of Marek’s disease (MD) and possible mechanisms of immunity induced by MD vaccine. J Vet Med Sci 60:1–8
Article
CAS
PubMed
Google Scholar
Dalgaard T, Boving MK, Handberg K, Jensen KH, Norup LR, Juul-Madsen HR (2009) MHC expression on spleen lymphocyte subsets in genetically resistant and susceptible chickens infected with Marek’s disease virus. Viral Immunol 22:321–327
Article
CAS
PubMed
Google Scholar
Nazerian K, Lee LF, Yanagida N, Ogawa R (1992) Protection against Marek’s disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek’s disease virus. J Virol 66:1409–1413
CAS
PubMed
PubMed Central
Google Scholar
Nazerian K, Witter RL, Lee LF, Yanagida N (1996) Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek’s disease virus. Avian Dis 40:368–376
Article
CAS
PubMed
Google Scholar
Omar AR, Schat KA, Lee LF, Hunt HD (1998) Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek’s disease herpesvirus glycoprotein B. Vet Immunol Immunopathol 62:73–82
Article
CAS
PubMed
Google Scholar
Murthy KK, Calnek BW (1979) Marek’s disease tumor-associated surface-antigen (matsa) in resistant versus susceptible chickens. Avian Dis 23:831–837
Article
CAS
PubMed
Google Scholar
McColl KA, Calnek BW, Harris WV, Schat KA, Lee LF (1987) Expression of a putative tumor-associated surface antigen on normal versus Marek’s disease virus-transformed lymphocytes. J Natl Cancer Inst 79:991–1000
CAS
PubMed
Google Scholar
Podack ER, Strbo N, Sotosec V, Muta H (2002) CD30-governor of memory T cells? Ann N Y Acad Sci 975:101–113
Article
CAS
PubMed
Google Scholar
Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER, Iwakura Y, Yoshikai Y (2010) CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses. J Immunol 185:7671–7680
Article
CAS
PubMed
Google Scholar
Parvizi P, Andrzejewski K, Read LR, Behboudi S, Sharif S (2010) Expression profiling of genes associated with regulatory functions of T-cell subsets in Marek’s disease virus-infected chickens. Avian Pathol 39:367–373
Article
CAS
PubMed
Google Scholar
Matsuyama-Kato A, Murata S, Isezaki M, Kano R, Takasaki S, Ichii O, Konnai S, Ohashi K (2012) Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek’s disease virus. Virol J 9:94
Article
CAS
PubMed
PubMed Central
Google Scholar
Schub D, Janssen E, Leyking S, Sester U, Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M, Schmidt T (2015) Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. J Infect Dis 211:600–612
Article
PubMed
Google Scholar
Parvizi P, Read LR, Abdul-Careem MF, Sarson AJ, Lusty C, Lambourne M, Thanthrige-Don N, Burgess SC, Sharif S (2009) Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically resistant and susceptible chickens infected with Marek’s disease virus. Vet Immunol Immunopathol 132:209–217
Article
CAS
PubMed
Google Scholar
Gimeno IM (2008) Marek’s disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26(Suppl 3):C31–41
Article
CAS
PubMed
Google Scholar
Wu C, Gan J, Jin Q, Chen C, Liang P, Wu Y, Liu X, Ma L, Davison F (2009) Revaccination with Marek’s disease vaccines induces productive infection and superior immunity. Clin Vaccine Immunol 16:184–193
Article
CAS
PubMed
Google Scholar
Rouse BT, Kaistha SD (2006) A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Clin Infect Dis 42:810–817
Article
PubMed
Google Scholar
Levy AM, Heller ED, Leitner G, Davidson I (1999) Effect of native chicken interferon on MDV replication. Acta Virol 43:121–127
CAS
PubMed
Google Scholar
Yang Q, Wei P, Chen H (2011) Cytokine responses and inducible nitrous oxide synthase expression patterns in neonatal chicken brain microglia infected with very virulent Marek’s disease virus strain YL040920. Vet Immunol Immunopathol 142:14–24
Article
CAS
PubMed
Google Scholar
Bacon LD, Hunt HD, Cheng HH (2001) Genetic resistance to Marek’s disease. Curr Top Microbiol Immunol 255:121–141
CAS
PubMed
Google Scholar
Witter RL (2001) Protective efficacy of Marek’s disease vaccines. Curr Top Microbiol Immunol 255:57–90
CAS
PubMed
Google Scholar
Djeraba A, Kut E, Rasschaert D, Quéré P (2002) Antiviral and antitumoral effects of recombinant chicken myelomonocytic growth factor in virally induced lymphoma. Int Immunopharmacol 2:1557–1566
Article
CAS
PubMed
Google Scholar
Gobel TW, Schneider K, Schaerer B, Mejri I, Puehler F, Weigend S, Staeheli P, Kaspers B (2003) IL-18 stimulates the proliferation and IFN-gamma release of CD4+ T cells in the chicken: conservation of a Th1-like system in a nonmammalian species. J Immunol 171:1809–1815
Article
PubMed
Google Scholar
Parvizi P, Mallick AI, Haq K, Haghighi HR, Orouji S, Thanthrige-Don N, St Paul M, Brisbin JT, Read LR, Behboudi S, Sharif S (2012) A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek’s disease virus and hinders tumor development in chickens. Viral Immunol 25:394–401
Article
CAS
PubMed
Google Scholar
Parvizi P, Abdul-Careem MF, Mallick AI, Haq K, Haghighi HR, Orouji S, Heidari M, Behboudi S, Sharif S (2014) The effects of administration of ligands for Toll-like receptor 4 and 21 against Marek’s disease in chickens. Vaccine 32:1932–1938
Article
CAS
PubMed
Google Scholar
Haunshi S, Cheng HH (2014) Differential expression of Toll-like receptor pathway genes in chicken embryo fibroblasts from chickens resistant and susceptible to Marek’s disease. Poult Sci 93:550–555
Article
CAS
PubMed
Google Scholar
Kamil JP, Tischer BK, Trapp S, Nair VK, Osterrieder N, Kung HJ (2005) vLIP, a viral lipase homologue, is a virulence factor of Marek’s disease virus. J Virol 79:6984–6996
Article
CAS
PubMed
PubMed Central
Google Scholar
Schippers T, Jarosinski K, Osterrieder N (2015) The ORF012 gene of Marek’s disease virus type 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth. J Virol 89:1348–1363
Article
PubMed
CAS
Google Scholar
Lee LF, Heidari M, Sun A, Zhang H, Lupiani B, Reddy S (2013) Identification and in vitro characterization of a Marek’s disease virus-encoded Ribonucleotide reductase. Avian Dis 57:178–187
Article
PubMed
Google Scholar
Schumacher D, Tischer BK, Trapp S, Osterrieder N (2005) The protein encoded by the US3 orthologue of Marek’s disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J Virol 79:3987–3997
Article
CAS
PubMed
PubMed Central
Google Scholar
Chbab N, Egerer A, Veiga I, Jarosinski KW, Osterrieder N (2010) Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek’s disease virus (MDV). Vet Res 41:56
Article
PubMed
PubMed Central
CAS
Google Scholar
Tahiri-Alaoui A, Smith LP, Kgosana L, Petherbridge LJ, Nair V (2013) Identification of a neurovirulence factor from Marek’s disease virus. Avian Dis 57:387–394
Article
PubMed
Google Scholar
Trapp-Fragnet L, Bencherit D, Chabanne-Vautherot D, Le Vern Y, Remy S, Boutet-Robinet E, Mirey G, Vautherot JF, Denesvre C (2014) Cell cycle modulation by Marek’s disease virus: the tegument protein VP22 triggers S-phase arrest and DNA damage in proliferating cells. PLoS One 9:e100004
Article
PubMed
PubMed Central
CAS
Google Scholar
Tischer BK, Schumacher D, Chabanne-Vautherot D, Zelnik V, Vautherot JF, Osterrieder N (2005) High-level expression of Marek’s disease virus glycoprotein C is detrimental to virus growth in vitro. J Virol 79:5889–5899
Article
CAS
PubMed
PubMed Central
Google Scholar
Chbab N, Chabanne-Vautherot D, Francineau A, Osterrieder N, Denesvre C, Vautherot JF (2009) The Marek’s disease virus (MDV) protein encoded by the UL17 ortholog is essential for virus growth. Vet Res 40:28
Article
PubMed
PubMed Central
CAS
Google Scholar